BMS 6081
Generic Name: glipizide/metformin
Pill imprint BMS 6081 has been identified as Metaglip 2.5 mg / 250 mg.
Metaglip is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy.
Metaglip 2.5 mg / 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Metaglip Images
- Generic Name:
- glipizide/metformin
- Imprint:
-
BMS
6081 - Strength:
- 2.5 mg / 250 mg
- Color:
- Pink
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
povidone
croscarmellose sodium
magnesium stearate
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00087-6081
Advertisement
More Metaglip resources
Search Again
